Browse Articles
Discover research articles across all indexed journals
The complete genome of ‘Candidatus Phytoplasma phoenicium’ highlights carboxylic acids as primary carbon and energy substrates in phytoplasmas
Abstract Phytoplasmas are wall-less plant pathogens characterized by highly reduced genomes and limited metabolic capabilities, leading to an obligate host dependency. Since phytoplasma axenic cultivation has not yet been achieved, genomic approaches are essential to unravelling their biological and pathogenic traits. However, such insights are currently hindered by the scarcity of complete genomes and the lack of data for several clades, as is the case for the quarantine-relevant ‘ Candidatus Phytoplasma phoenicium’ (group 16SrIX-B), the causal agent of the severe stone-fruit disease almond witches’ broom (AlmWB). In this study, we present the complete genome sequence of the Lebanese strain F1A, which consists of a 552,248 bp chromosome with a 24.29% GC content and encodes 450 protein-coding genes. Comparative analyses with 16SrIX group draft genomes revealed high conservation among Lebanese AlmWB strains; however, comparisons with related 16SrIX-C phytoplasmas were limited by their low assembly completeness. Beyond providing a complete reference genome for this phytoplasma group, the F1A chromosome revealed distinct metabolic features. Strain F1A lacks the upper glycolytic pathway, indicating a metabolism that relies on glycerol-3-phosphate uptake and carboxylic acid fermentation. Notably, in addition to the conserved malate-to-acetate pathway, F1A encodes a complete citrate lyase complex, suggesting the potential for citrate utilization. Phylogenetic analysis of the associated 2-hydrocarboxylate symporter revealed the widespread occurrence of two phylogenetically distinct variants in phytoplasmas. Apart from the deduced metabolic capacities, the predicted effector repertoire shows similarities with those of other phytoplasmas, including proteins associated with branch proliferation and witches’ broom symptoms. Overall, these findings link genome reduction to host-dependent carboxylic acid metabolism in a quarantine-relevant phytoplasma, establishing a framework for comparative and functional studies of 16SrIX phytoplasmas and providing a basis for future investigations of AlmWB ecology and pathogenicity.
Super Cost‐Effective and Scalable Imine‐Based Sorbent With Field Attraction and In Situ Fixation for Efficient Capture of Diverse Iodine Species under Industrial Conditions (Adv. Mater. 40/2026)
Constructing Coupled Ion‐Electron Pathways for Efficient Oxygen Chemistry in Solid‐State Lithium‐Oxygen Batteries
ABSTRACT Solid‐state lithium‐oxygen batteries (SSLOBs) are ideal energy storage systems because of their intrinsic safety and ultrahigh theoretical energy density. However, practical implementation is severely hindered by sluggish oxygen‐redox kinetics at solid‐state air cathodes, where achieving fast ionic/electronic transport and high catalytic activity concurrently remains a formidable challenge. Here, we demonstrate a strategy to construct coupled ion‐electron pathways within a monolithic mixed ionic‐electronic catalyst (MMIEC) cathode. Using LiCoO 2 (LCO) as a model system, a seamless interface with the solid electrolyte is established via an ultrafast thermal integration process, creating continuous percolation networks for both Li + and electrons. These coupled pathways ensure unimpeded charge transport at the electrochemical interface, while surface‐enriched Co 3+ /Co 4+ redox couples act as intrinsically active catalytic centers. This architecture mediates oxygen‐redox reactions by accelerating LiO 2 * formation during discharge and promoting the reversible decomposition of Li 2 O 2 upon charge. Consequently, the MMIEC‐based SSLOB delivers an ultrahigh discharge capacity of 12970 mAh g −1 , maintains stable cycling for more than 400 cycles, and exhibits a reduced voltage polarization of 1.0 V. This work demonstrates that coupling catalytic activity with robust ionic‐electronic pathways is crucial for advancing high‐performance SSLOBs.
A ferroptosis-suppressive tumor state to drive chemoradiotherapy resistance and define a therapeutic vulnerability in muscle-invasive bladder cancer.
195 Background: Bladder-preserving chemoradiotherapy (CRT) is a curative alternative to radical cystectomy for muscle-invasive bladder cancer (MIBC), yet durable disease control is limited by intrinsic resistance whose basis remains unclear. Methods: We performed transcriptomic profiling of pretreatment tumors from 179 patients uniformly treated with CRT and integrated gene expression with clinical outcomes, molecular subtype features, and immune contexture. Functional validation used CRT-resistant bladder cancer models and genome-wide CRISPR/Cas9 knockout screening under irradiation (IR). Results: We identified a ferroptosis-suppressive transcriptional signature (FSS) that defines a distinct resistance state and independently predicts radiographic progression-free and overall survival after CRT. High-FSS tumors showed inferior outcomes and were enriched for basal/squamous and immune-excluded phenotypes with reduced immune infiltration. This state was recapitulated in experimentally derived CRT-resistant models. CRISPR screening under IR identified core ferroptosis suppressor genes as essential survival dependencies and radiosensitizers, and pharmacologic ferroptosis induction restored radiosensitivity in resistant cells. Conclusions: A ferroptosis-suppressive state represents a mechanistically defined resistance program linking tumor-intrinsic transcriptional circuitry, immune microenvironment architecture, and therapeutic vulnerability. These findings establish ferroptosis regulation as a clinically actionable axis for risk stratification and therapeutic intensification in bladder-preserving MIBC. Multivariable Cox models evaluating clinicopathologic factors and FSS for radiographic progression-free survival. Multivariable Cox for rPFS HR (95% CI) P value Multivariable Cox for OS HR (95% CI) P value FSS High / Low 2.58 (1.64-4.05) <0.001*** FSS High / Low 2.79 (1.66-4.67) <0.001*** N1 / N0 2.44 (1.46-4.08) 0.001** LVI (+) / (-) 2.18 (1.14-4.16) 0.018* Ba/Sq / Others 2.06 (1.26-3.36) 0.004** With variant / pure UC 1.69 (0.89-3.19) 0.109 LVI (+) / (-) 1.71 (1.00-2.92) 0.048* N1 / N0 1.64 (0.92-2.95) 0.095 With variant / pure UC 1.52 (0.84-2.77) 0.168 Ba/Sq / Others 1.40 (0.82-2.40) 0.214 Grade high / low 1.38 (0.49-3.88) 0.539 cT stage > T2 / <T2 1.16 (0.70-1.92) 0.561 cT stage > T2 / <T2 1.33 (0.85-2.08) 0.219 Grade high / low 1.04 (0.33-3.30) 0.942 CIS (+) / (-) 0.57 (0.30-1.07) 0.081 Age ≥ 75 / <75 0.70 (0.38-1.28) 0.245 Age ≥ 75 / <75 0.55 (0.32-0.96) 0.036* CIS (+) / (-) 0.41 (0.18-0.97) 0.041* rPFS, radiographic progression-free survival; OS, overall survival (OS); HR, Hazard ratios; CI, confidence intervals; FSS, ferroptosis-suppressive signature; LVI, lymphovascular invasion; Ba/Sq, basal/squamous subtype; UC, urothelial carcinoma; CIS, carcinoma in situ. * P < 0.05; ** P < 0.01; *** P < 0.001.
<i>N/Si</i> -Doped Nonbenzenoid Buckybowls with Tunable Configurations and Optoelectronic Properties
Timing of the first dressing change after CVC insertion in pediatric critically ill patients: a randomized controlled, non-inferiority trial
Diblock Copolymer Engineered Swim Bladder Membrane Enables Spatiotemporal Synchronized Defense and Pro‐Healing in Challenging Soft Tissue Regeneration
ABSTRACT The exposed and microbe‐rich microenvironment requires the soft tissue regeneration materials to balance conflicting characteristics, including biodegradation, mechanical stability, and biological activity. Herein, this research engineers a glycoprotein‐inspired soft tissue regeneration membrane by precisely grafting the diblock copolymer from a robust fish swim bladder collagen matrix via surface‐initiated reversible addition‐fragmentation chain transfer polymerization. Benefitting from the naturally dense fibrous network and in situ crosslinking, the modified collagen membrane maintains structural integrity and mechanical support prior to tissue maturation, followed by progressive degradation to facilitate new tissue replacement. More importantly, the grafted diblock copolymer orchestrates a spatiotemporal synchronized defense and pro‐healing efficacy. It not only maintains microbial homeostasis while constructing a hydration‐based exclusion barrier against pathogenic biofilms, but also activates integrin‐mediated cell adhesion and various regeneration‐related behaviors. Consequently, this sophisticated design harmonizes degradation kinetics and anti‐biofilm efficacy with the spatiotemporal demands of healing. As a result, the diblock copolymer engineered swim bladder membrane transcends passive scaffolding, offering comprehensive and active protection and promotion for challenging soft tissue regeneration.
Closing the diagnostic gap: A three-step AI safety-net workflow to capture missed lung nodules on chest radiographs in routine clinical practice.
3 Background: Incidentally encountered lung nodules on chest radiographs (CXRs) are frequently overlooked in routine clinical practice. A Thai institutional study demonstrated that up to 79% of lung cancers visible in retrospect on CXRs were missed by both radiologists and clinicians (Chutivanidchayakul et al., Clin Imaging 2023). Even when AI systems flag suspicious nodules, clinician non-concordance remains a critical barrier. We implemented a three-step safety-net workflow integrating AI detection, systematic monitoring, and radiologist second-look review through a dedicated lung nodule clinic to close this diagnostic gap. Methods: Over 1 year, all CXRs obtained for any clinical indication at Phrapokklao Hospital and its spoke network in Chanthaburi, Thailand, were analyzed by qXR (Qure.ai) for lung nodule detection. The workflow comprised: (1) AI-flagged detection of actionable high-risk lung nodules (HLNMs), (2) centralized monitoring to capture all flagged cases regardless of treating physician response, and (3) radiologist second-look review to validate findings and refer confirmed cases for diagnostic CT and biopsy. Lung cancers were histologically confirmed and staged per AJCC 8th edition. Results: Of 107,238 CXRs processed, qXR identified 691 actionable HLNMs (0.64%). Through the safety-net pathway, 382 (55.3%) underwent diagnostic CT and 124 (32.5%) proceeded to biopsy. Forty-seven lung cancers were confirmed (1 per 2,282 CXRs), plus 2 non-lung metastatic cancers. Among 33 patients with complete staging: stage I (n=3), stage II (n=11), stage IIIA–C (n=9), and stage IV (n=10). Overall, 23/47 (48.9%) were early-stage (I–III). Conclusions: AI detection alone is insufficient when clinicians fail to act on flagged findings. Our three-step safety-net model effectively bridges the gap between AI identification and clinical action, capturing lung cancers that would otherwise be missed. Nearly half were early-stage, demonstrating meaningful diagnostic acceleration. This approach addresses an underrecognized failure point in AI-augmented workflows and offers a scalable model for reducing missed lung cancer in routine practice.
Differences in structural color and population genetic structure of Western and Central Palearctic Polyommatus icarus populations
Abstract The blue structural coloration of male Polyommatus icarus butterflies functions as a sexual signaling trait and exhibits remarkable spectral stability within populations despite being generated by highly complex photonic nanoarchitectures. The correlation of the blue sexual signaling color and population genetic variation of the butterflies was investigated across the Western and Central Palearctic regions. Dorsal wing reflectance spectra was measured for 95 male specimens and compared with the population genetic structure revealed in 99 specimens by 18 recently developed microsatellites. Reflectance measurements indicated a clear separation between the European and Central Asian populations, consistent with our previous findings, while the intermediate populations near the Ural Mountains exhibited distinct European spectral characteristics. In contrast, genetic variation showed limited structuring and correlated primarily with geographic distance, as indicated by a significant isolation-by-distance pattern. Thus, although both reflectance and genetic variations are geographically structured, spectral properties are only weakly correlated with genetic differentiation. Populations near the Ural Mountains exhibited genetic ancestry linked to Central Palearctic groups, while displaying distinct Western Palearctic coloration, suggesting that the focal species’ sexual signaling is strongly influenced by local factors. These findings suggest that sexual signaling coloration may evolve at least partially independently of the neutral genetic background, offering additional insight into evolutionary divergence across broad geographic scales.
Localized Temperature Monitoring in Mouse Brain during Light Delivery via a Non‐Planar Tapered Fiber‐Integrated µRTD Sensor (Adv. Mater. 41/2026)
Asymmetric Oxygen Bridges: A Unified Design Framework for Enhanced Catalysis
ABSTRACT The asymmetric oxygen bridges (AOBs), composed of asymmetric Metal 1 ‐Oxygen‐Metal 2 (M 1 ‐O‐M 2 ) with intrinsic electronic and geometric asymmetry, have gained significant attention in heterogeneous catalysis. The intrinsic asymmetric coordination induces unique and controllable interfacial charge polarization, which have recently inspired novel design concepts to achieve improved structure‐activity relationships. However, fully exploiting their potential requires a systematic framework to unify design principles. This review systematically presents the unique characteristics of AOBs originated by the different valence states, ionic radius and electronegativities of oxygen bridged metal sites. By analyzing the structure‐activity relationship between atomic‐scale charge polarization and lattice strain with macroscopic functionality, the enhancing mechanisms of AOBs from categories including heteronuclear AOBs, homonuclear hetero‐valent AOBs, heteroatoms modified AOBs and dynamically tunable AOBs is illustrated. These insights will provide new opportunities for understanding of catalytic mechanisms, the design of highly efficient catalysts and the development of more efficient energy conversion technologies.
Second primary malignancy risk in Hodgkin lymphoma survivors in the modern treatment era: A SEER MP-SIR analysis, 2000–2022.
253 Background: Second primary malignancies (SPMs) remain a leading cause of late mortality among Hodgkin lymphoma (HL) survivors. Contemporary estimates reflecting reduced-field radiotherapy and the introduction of brentuximab vedotin and PD-1 inhibitors are limited. As modern HL therapy continues to shift toward individualized, risk-adapted approaches, updated population-level data are essential to assess whether these therapeutic advances have translated into reduced late toxicities. Methods: Patients with first primary HL diagnosed 2000–2022 were identified in SEER-17 registries (November 2024 submission). Follow-up began 12 months after diagnosis. Standardized incidence ratios (SIRs) and excess absolute risks (EARs per 10,000 person-years) were calculated using SEER*Stat MP-SIR, restricting second events to subsequent malignant tumors (event number ≥2). Analyses were stratified by age at HL diagnosis and calendar period. Results: Among 39,430 HL survivors contributing 366,836 person-years, 3,092 SPMs were observed (SIR 1.60, 95% CI 1.54–1.66; EAR 31.59). SIR declined from 1.78 (2000–2009) to 1.42 (2010–2022) (p-trend < 0.001). Highest relative risks occurred in patients diagnosed age 5–19 years, with SIRs 4.03–8.42. Lung cancer remained the most common solid SPM in older survivors (SIR ~4× risk), emphasizing the ongoing importance of smoking cessation and screening. These trends indicate a decline in SPM incidence in more recently treated patients. Follow-up for the most recent period was shorter, which may underestimate late SPMs, and individual treatment details were not available. Conclusions: Overall, SPM risk in HL survivors has declined compared with historical cohorts and is now only about 60% higher than the general population. These updated findings provide actionable guidance for risk-adapted survivorship care, highlighting the importance of targeted lung-cancer screening in older patients and offering practical information for counseling patients about their long-term risk.
Machine learning driven forward-reverse design of Ag–ZnO–PEEK nanocomposites for sustainable biomass and lipid enhancement in Chlorella vulgaris AK_123 with integrated anti-bacterial activity
An Extravascular Synergistic Cocktail Therapeutic Strategy Based on Lanifibranor Loaded Self‐Healing Bioelastomer for Abdominal Aortic Aneurysms (Adv. Mater. 39/2026)
Non‐Fullerene Acceptor Photo‐Charge Enabled Stretchable Photovoltaic Robustness Under 90% Tensile Strain and 30% Strain Cycles
ABSTRACT Stretchable organic solar cells (s‐OSCs) are promising for wearable electronics but suffer from performance degradation under deformation. We improve this situation by leveraging the property of bulk photo‐charge generation in non‐fullerene acceptors (NFAs). Due to its weak dependence on blend morphology, the bulk photo‐charge generation pathway helps alleviate the exciton utilization loss in elastomer‐diluted photoactive layer. Screened by the molecular descriptor of π‐π quadrupole moment (Q ZZ ) and identified by the subsequent photovoltaic performance measurements on single‐component device, AQx‐2F is selected from 130 NFAs with superior bulk photo‐charge generation capability. Incorporating SEEPS via sequential deposition (SD) confers a high fracture strain (ε f ) of 185% in the photoactive layer. Taking advantage of it, the s‐OSC exhibits a power conversion efficiency (PCE) of 9.8% with record photovoltaic robustness. It retains over 80% of its initial PCE both under a high tensile strain of 90% and after 1000 stretching‐releasing cycles at 30% strain. This photoactive layer also enables a flexible semi‐transparent OSC (FST‐OSC) that achieves the light utilization efficiency (LUE) comparable to rigid devices while maintaining mechanical stability. Rooted in emerging photo‐physics of organic photovoltaic materials, this work establishes a new strategy for photovoltaic robust s‐OSCs.
Assessing the impact of the COVID-19 pandemic on the diagnosis and staging of pancreatic cancer: A Surveillance, Epidemiology and End Results analysis.
130 Background: The COVID-19 pandemic markedly affected the U.S. health care system and may have altered the diagnosis and management of pancreatic cancer. We examined national trends in pancreatic cancer diagnoses before and throughout the first two years after the onset of COVID-19 in the United States, using the latest data from the Surveillance, Epidemiology, and End Results (SEER) database. Methods: We queried the SEER database for cases of pancreatic cancer diagnosed between 2019 and 2021 using ICD-O-3 codes C25.0-C25.9. Disease stage was categorised as localised, regional, distant, or unknown according to the SEER combined summary staging system. Case counts and incidence rates were compared across 2019, 2020, and 2021, with year-to-year differences assessed for statistical significance using χ² tests. Results: The overall number of cases of PDAC diagnosed in 2019, 2020, and 2021 (including year-to-year changes) were 13,457, 13,153 (-2.3%, p<0.05), and 13,998 (+6.4%, p<0.001). Among the known SEER summary staging for PDAC, 52.3% of cases were categorised as “distant” at the time of diagnosis in 2019, compared to 53.6% (+2.4%, p<0.05) in 2020, and 52.0% (-2.8%, p<0.05) in 2021. This reflected an overall change of -0.5% in “distant” PDAC diagnoses from 2019 to 2021 (p>0.05). Conclusions: Significantly fewer cases of PDAC were diagnosed in 2020 compared with 2019, followed by a significant increase in 2021 to above pre-pandemic levels. The proportion diagnosed as distant was significantly higher in 2020 than in 2019 but did not differ significantly between 2019 and 2021. These findings suggest a transient shift toward more advanced-stage PDAC diagnoses during the first year of the COVID-19 pandemic with likely delays in diagnosis, which returned to baseline in 2021.
Perceptually coherent sound-space traversal for interactive systems via embeddings, VAE priors and diffusion decoding
A Super‐Adhesive Air Filter With Capillarity‐Mediated Spontaneous Particle Absorption via Dynamic Bond Exchange (Adv. Mater. 42/2026)
Local Charge Engineering Through Anion–Cation Co‐modulation for Multifunctional Programmable Electromagnetic Wave Attenuation
ABSTRACT Electromagnetic wave absorption (EMWA) materials with tunable responses are critically important for operation in complex electromagnetic environments. In this study, a novel dual‐ion co‐modulation strategy is introduced to overcome the limited controllability of conventional EMWA materials. By employing a coordination‐mediated gelation phase transformation approach, a series of transition metal sulfide/sulfur–nitrogen co‐doped carbon (M x S y /SNC, M = Fe, Co, Ni, or Cu) aerogels are successfully fabricated. First‐principles calculations demonstrate that N,S co‐doping tunes the electronic structure of the carbon matrix, enhancing local charge imbalance and promoting dipole polarization, which significantly broadens the EMWA band. At 1.65 mm, the effective absorption bandwidth almost covers the entire Ku band. Furthermore, cation‐induced modulation of the electronic configuration enables precise tuning of the built‐in electric field and dielectric response, resulting in customizable absorption peaks and bandwidths. All samples achieve a minimum reflection loss ( RL min ) below −60 dB, with the RL min peak frequency shifting from 17.44 GHz to 11.6, 9.84, and 5.12 GHz depending on the metal ion. Finally, a low‐frequency antenna and a one‐to‐two power divider are constructed, demonstrating strong application potential in the communications field. This study provides a new pathway for designing high‐performance, programmable EMWA systems and multifunctional materials.
Engineered <i>Escherichia coli</i> Nissle 1917 carrying D-lactate dehydrogenase to suppress glioblastoma malignancy via gut-brain axis reprogramming.
76 Background: Glioblastoma (GBM) is the most aggressive primary brain tumor with limited therapeutic options and poor prognosis. Metabolic reprogramming is a hallmark of GBM, yet the role of D-lactate, an understudied stereoisomer of lactate, remains elusive. While L-lactate has been extensively characterized, we identified D-lactate as a systemically circulating oncometabolite that disrupts intestinal homeostasis via the gut-brain axis, representing an unexplored therapeutic vulnerability in GBM. Methods: Through untargeted metabolomics of patient-derived GBM stem-like cells and brain organoid co-culture models, we characterized D-lactate as a key tumor-secreted metabolite. We screened human and murine gut microbiota to isolate D-lactate-metabolizing bacteria, cloned six highly active D-lactate dehydrogenases (LDHDs), and engineered probiotic Escherichia coli Nissle 1917 (EcN) to express optimal variants. Lipid-coated therapeutic bacteria (Lipo-EcN-LDHD) were developed to enhance gastric stability and intestinal colonization. Therapeutic efficacy was evaluated in orthotopic GBM xenograft models using bioluminescence imaging, survival analysis, histopathology, and metagenomic sequencing. Results: GBM-bearing mice exhibited ~4-fold elevation in serum D-lactate (~150 μM) compared to controls, accompanied by intestinal shortening and dysbiosis. Natural D-lactate-metabolizing bacteria significantly suppressed tumor growth and prolonged survival. Enzymatic characterization identified MeLDHD3 as the most catalytically efficient variant. Oral administration of Lipo-EcN-MeLDHD3 achieved robust intestinal colonization, reduced systemic D-lactate levels, significantly inhibited orthotopic tumor growth ( P <0.01), and prolonged survival ( P <0.05). Treatment restored gut microbiota homeostasis, reduced tumor Ki67 proliferation index, and attenuated D-lactate-mediated immunosuppressive microenvironment. Conclusions: This study establishes D-lactate as a novel metabolic target in GBM and demonstrates the first synthetic biology-inspired "gut-heals-brain" therapeutic strategy. Engineered probiotic EcN expressing LDHD enables non-invasive, sustained systemic clearance of tumor-derived D-lactate, offering a safe, precision metabolic intervention for GBM. This platform validates the gut-brain axis as a druggable conduit for brain tumor therapy and provides a transformative paradigm for treating metabolically driven malignancies.